Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.

Journal: International journal of cardiology
PMID:

Abstract

INTRODUCTION: We conducted the first comprehensive evaluation of the therapeutic value and safety profile of transcatheter mitral edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) in individuals concurrently afflicted with cancer.

Authors

  • Konstantinos Marmagkiolis
    Tampa Heart, Tampa, Florida; Department of Internal Medicine, University of South Florida, Tampa, Florida.
  • Dominique J Monlezun
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
  • Jaime Caballero
    University of South Florida, Tampa, FL, United States of America; Tampa General Hospital, Tampa, FL, United States of America.
  • Mehmet Cilingiroglu
    Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, United States.
  • Matthew N Brown
    University of Texas Houston, MD Anderson Cancer Center, Houston, TX, United States of America.
  • Vlasis Ninios
    2nd Cardiology Department, Interbalkan Medical Center, 55535 Thessaloniki, Greece.
  • Abdelrahman Ali
    University of Texas Houston, MD Anderson Cancer Center, Houston, TX, United States of America.
  • Cezar A Iliescu
    University of Texas Houston, MD Anderson Cancer Center, Houston, TX, United States of America.